UNITED THERAPEUTICS CORP
UTHR · NASDAQ
更新於 2026-10-13 13:57:33
$544.18-1.07%
- 今日最高
- $553.99
- 今日最低
- $543.20
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $553.49
- 昨天收盤價
- $550.10
- 成交量
- 840.64K
- 市值
- $23.59B
- 市盈率（P/E）
- 18.10X
- 每股收益（EPS）
- $27.95
昨天價格區間
$547.76$555.58
52週價格區間
$409.07$609.35
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 藥品製造商 - 專科及仿製藥
- 總部
- 1000 SPRING STREET, SILVER SPRING, MD, UNITED STATES, 20910
- 國家
- 美國
- 上市日期
- 1999-06-17
- 財年截止
- 十二月
- 流通股數
- 42.45M
- CIK
- 0001082554
- 官方網址
- www.unither.com
United Therapeutics Corporation是一間生物科技公司，致力於在美國及國際間開發及商業化產品，以滿足慢性及危及生命疾病患者未被滿足的醫療需求。公司總部位於馬里蘭州銀泉市。
財務指標
營業收入
2026-06-30
$783.3M
2026-03-31
$781.5M
2025-12-31
$790.2M
2025-09-30
$799.5M
營業支出
2026-06-30
$353M
2026-03-31
$322.3M
2025-12-31
$329.3M
2025-09-30
$309.3M
淨利潤
2026-06-30
$333M
2026-03-31
$274.9M
2025-12-31
$364.3M
2025-09-30
$338.7M
淨利潤率
2026-06-30
42.51%
2026-03-31
35.17%
2025-12-31
46.1%
2025-09-30
42.36%
每股收益
2026-06-30
$7.27
2026-03-31
$5.82
2025-12-31
$7.70
2025-09-30
$7.16
息稅折舊攤銷前利潤
2026-06-30
$399.8M
2026-03-31
$343.9M
2025-12-31
$469.9M
2025-09-30
$462.9M
有效稅率
2026-06-30
10.65%
2026-03-31
13.63%
2025-12-31
17.95%
2025-09-30
22.67%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $783.3M | $781.5M | $790.2M | $799.5M |
| 營業支出 | $353M | $322.3M | $329.3M | $309.3M |
| 淨利潤 | $333M | $274.9M | $364.3M | $338.7M |
| 淨利潤率 | 42.51% | 35.17% | 46.1% | 42.36% |
| 每股收益 | $7.27 | $5.82 | $7.70 | $7.16 |
| 息稅折舊攤銷前利潤 | $399.8M | $343.9M | $469.9M | $462.9M |
| 有效稅率 | 10.65% | 13.63% | 17.95% | 22.67% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。